A phase II study of bevacizumab, oxaliplatin, and docetaxel in locally advanced and metastatic gastric and gastroesophageal junction cancers
Titel:
A phase II study of bevacizumab, oxaliplatin, and docetaxel in locally advanced and metastatic gastric and gastroesophageal junction cancers
Auteur:
El-Rayes, B.F. Zalupski, M. Bekai-Saab, T. Heilbrun, L.K. Hammad, N. Patel, B. Urba, S. Shields, A.F. Vaishampayan, U. Dawson, S. Almhanna, K. Smith, D. Philip, P.A.